Moving Forward shortlisted for HSJ Partnership Awards

Discussing the news that Breast Cancer Care’s Moving Forward service, run in partnership with 70 NHS hospital trusts and health boards across the UK...

22 January 2019

We respond to NICE’s approval of abemaciclib for routine NHS use

The National Institute for Health and Care Excellence (NICE) has published new draft guidance recommending breast cancer drug abemaciclib with an...

17 January 2019

Treatment options for secondary breast cancer increase as abemaciclib approved on NHS

Responding to the decision by the National Institute for Health and Care Excellence (NICE) to approve abemaciclib with an aromatase inhibitor for...

17 January 2019

Cancer Patient Experience Survey will continue

Responding to the decision by the Department of Health and Social Care to give the Cancer Patient Experience Survey permanent exemption from the...

16 January 2019

Our response to study suggesting a comprehensive new method to predict breast cancer risk

New research published in journal Genetics in Medicine suggests that scientists have created the most comprehensive method to date to predict an...

15 January 2019

Perjeta approved in Scotland for secondary breast cancer

Discussing the news that the Scottish Medical Consortium (SMC) has approved pertuzumab (Perjeta) for use on NHS Scotland to treat secondary...

14 January 2019

We respond to approval of Perjeta for secondary breast cancer on NHS in Scotland

The Scottish Medicines Consortium (SMC) has announced its decision to approve life-extending drug Perjeta (pertuzumab) for routine use in treating...

14 January 2019

Our response to the publication of the NHS Long Term Plan

The Long Term Plan for the NHS in England has today (7 January 2019) been published by the Prime Minister, Rt Hon Theresa May MP, and the Chief...

7 January 2019

NHS Long Term Plan “barely scratches the surface” of huge challenges facing Health Service

Responding to the publication of the NHS Long Term Plan, Samia al Qadhi, Chief Executive of Breast Cancer Care, says: “This long-overdue...

7 January 2019